In cancer cells, BRCA1-associated protein 1 (BAP1) removes monoubiquitin from ubiquitinated H2A at lysine 119 (H2Aub) on the SLC7A11 promoter, thereby suppressing its expression in cells treated with erastin and activating ATF4 [173,174]. This evidence concerns the gene BAP1 and cancer.